Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yadong Yuan
Analysis of the First Therapeutic-Target-Achieving Time of Warfarin Therapy and Associated Factors in Patients With Pulmonary Embolism
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Related publications
Thrombolytic Therapy and Mortality in Patients With Acute Pulmonary Embolism
Archives of Internal Medicine
“Radial” Approach to High Risk Pulmonary Embolism – Transcubital Catheter Directed Intervention as a First-Line Therapy in Patients With Clinically Massive and Submassive Pulmonary Embolism.
Cardiologia Croatica
Cardiovascular Medicine
Cardiology
Identification of Environmental and Genetic Factors That Influence Warfarin Time in Therapeutic Range
Genetics and Molecular Biology
Genetics
Molecular Biology
Do Patients With Submassive Pulmonary Embolism Benefit From Thrombolytic Therapy?
Cleveland Clinic Journal of Medicine
Medicine
Pharmaceutical Care Increases Time in Therapeutic Range of Patients With Poor Quality of Anticoagulation With Warfarin
Frontiers in Pharmacology
Pharmacology
Nebulized Tranexamic Acid Therapy for Hemoptysis Associated With Submassive Pulmonary Embolism
Journal of Aerosol Medicine and Pulmonary Drug Delivery
Pulmonary
Respiratory Medicine
Pharmacology
Pharmaceutical Science
Evaluating Time in Therapeutic Range for Hemodialysis Patients Taking Warfarin
Clinical Nephrology
Medicine
Nephrology
Outpatientversusinpatient Treatment in Patients With Pulmonary Embolism: A Meta-Analysis
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Prevalence of Pulmonary Embolism in Patients With Syncope
JAMA Internal Medicine
Internal Medicine
